Issue 7, 2023

Discovery and development of novel substituted monohydrazides as potent antifungal agents

Abstract

Novel substituted monohydrazides synthesized for this study displayed broad-spectrum activity against various fungal strains, including a panel of clinically relevant Candida auris strains. The activity of these compounds was either comparable or superior to amphotericin B against most of the fungal strains tested. These compounds possessed fungistatic activity in a time-kill assay and exhibited no mammalian cell toxicity. In addition, they prevented the formation of fungal biofilms. Even after repeated exposures, the Candida albicans ATCC 10231 (strain A) fungal strain did not develop resistance to these monohydrazides.

Graphical abstract: Discovery and development of novel substituted monohydrazides as potent antifungal agents

Supplementary files

Article information

Article type
Research Article
Submitted
10 Apr 2023
Accepted
30 May 2023
First published
14 Jun 2023

RSC Med. Chem., 2023,14, 1351-1361

Discovery and development of novel substituted monohydrazides as potent antifungal agents

N. Thamban Chandrika, K. D. Green, A. C. Spencer, O. V. Tsodikov and S. Garneau-Tsodikova, RSC Med. Chem., 2023, 14, 1351 DOI: 10.1039/D3MD00167A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements